Related Experiment Videos
[Severe acute respiratory syndrome (SARS)].
G Hoheisel1, A Wu, N Lee
1gerhard.hoheisel@t-online.de
Pneumologie (Stuttgart, Germany)
|June 19, 2003
Summary
Severe Acute Respiratory Syndrome (SARS), a novel coronavirus disease, presents with fever, cough, and myalgia. Early empirical treatment with ribavirin and corticosteroids shows promise in managing this severe respiratory illness.
Area of Science:
- Infectious Diseases
- Virology
- Pulmonology
Background:
- Severe Acute Respiratory Syndrome (SARS) emerged as a significant global health threat.
- The disease is caused by a novel coronavirus originating in Southeast Asia.
- Understanding SARS's clinical presentation and progression is crucial for effective management.
Observation:
- Typical symptoms include fever, cough, myalgia, chills, and rigor.
- Key laboratory findings include leucopenia, thrombocytopenia, and elevated LDH.
- Chest X-rays may show progressive peripheral consolidations, mimicking other pneumonias.
Findings:
- Advanced age and comorbidities negatively impact prognosis.
- Rapid respiratory compromise can occur even in younger patients.
- Empirical therapy with ribavirin and corticosteroids demonstrated success.
Implications:
- SARS can progress to acute respiratory distress syndrome (ARDS)-like respiratory failure.
- Mortality rates range from 5-10%, highlighting the disease's severity.
- Strict hygiene and quarantine measures are essential to control SARS transmission.